PROTAC-mediated PCSK9 degradation attenuates atherosclerosis and improves plaque composition via suppression of NF-κB/TNF-α pathway.
Authors: Wang X, Liu Y, Zhang QP, Zhang MC, Xia MD, Yang P, Chen SL, Guo WM, Liu M, Tang ZH, Fan G, Yang J
Journal: BMC medicine
art therapy
mental health
open access